After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for iBio Inc. (IBIO) shows that investor sentiment remained same, with the stock’s consolidated last price remained same by $0.00, or 0.83%, to $0.40. The iBio Inc. has recorded 87,111 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed iBio Reports Triple Milestone: In Vivo Proof-of-Concept for Three Programs, a Transformative Step in Advancing its Immuno-Oncology Pre-Clinical Pipeline Towards Clinical Development.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Stocks Info
iBio Inc. is listed on the AMEX in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $0.40 and fluctuated between $0.3990 as its day high and $0.3120 as its day low. The current market capitalization of iBio Inc. is $8.88M. A total of 1.41 million shares were traded on the day, compared to an average of 705.09K shares.
Insider Activity
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, IBIO has seen 1 BUY and 7 SELL insider trades, representing the acquisition of 75,833 and the disposition of 131,552 shares. Over the last 12 months, there were 6 BUYs and 12 SELLs from insiders. Insiders purchased 488,738 shares during that period but sold 149,305.
In the most recent transaction, Brenner Martin sold 5,011 shares of IBIO for 0.31 per share on Aug 28. After the transaction, the insider now owns 196,865 company shares. In a previous transaction on Jul 27, Brenner Martin sold 4,515 shares at 0.51 per share. IBIO shares that owns now total 201,876.
Among the insiders who sold shares, Brenner Martin disposed of 47,020 shares on Jul 12 at a per-share price of $0.59. This resulted in the insider holding 206,391 shares of IBIO after the transaction. In another insider transaction, Brenner Martin sold 4,184 shares at $0.68 per share on Jun 21. Company shares held by the insider now total 253,411.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for IBIO in the last 3 months, the mean price target is $1.00 with high estimates of $1.00 and low estimates of $1.00. In terms of 52-week highs and lows, IBIO has a high of $16.51 and a low of $0.26.
As of this writing, IBIO has an earnings estimate of -$3.42 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of -$3.42 per share and a lower estimate of -$3.42. The company reported an EPS of -$1.96 in the last quarter, which was 7.50% higher than expectations of -$2.12.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. IBIO’s latest balance sheet shows that the firm has $33.52M in Cash & Short Term Investments as of fiscal 2022. There were $27.79M in debt and $30.44M in liabilities at the time. Its Book Value Per Share was $1.32, while its Total Shareholder’s Equity was $63.48M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IBIO is Buy with a score of 0.00.
